Shah Hussain

Shah Hussain

Director/Board Member at MODERNA, INC.

Net worth: 66 766 $ as of 31/01/2026

61 year
Health Technology
Consumer Services
Finance

Profile

Shah Abbas Hussain occupies the position of Senior Partner at Shanghai Kangshiqiao Business Consulting Co. Ltd. He is also on the board of Teva Pharmaceutical Industries Ltd., Cochlear Ltd. and TargTex SA and President-Emerging Markets Asia Pacific at GlaxoSmithKline South Africa (Pty) Ltd. He previously occupied the position of Associate-Business Development at Eli Lilly & Co. President-Europe Operations at Eli Lilly & Co. Ltd. General Manager of Lilly Deutschland GmbH, General Manager for Lilly Pharma Holding GmbH, Managing Director at Lilly Ilaç Ticaret Ltd. Sti. Director-Sales & Marketing for Eli Lilly Ranbaxy Ltd. and Manager-District Sales at Eli Lilly Australia Pty Ltd. (which are all subsidiaries of Eli Lilly & Co.) and Global President-Pharmaceuticals & Vaccines at GlaxoSmithKline Plc and President-Emerging Markets & Asia Pacific at Genelabs Technologies, Inc. (a subsidiary of GlaxoSmithKline Plc). Shah Abbas Hussain received an undergraduate degree from Loughborough University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/12/2025 1,515 ( 0% ) 66 766 $ 31/01/2026

Shah Hussain active positions

CompaniesPositionStart
MODERNA, INC. Director/Board Member 02/10/2024
Director/Board Member -
Chairman -
Corporate Officer/Principal 01/12/2009
Director/Board Member 01/01/2024

Former positions of Shah Hussain

CompaniesPositionEnd
Chief Executive Officer 01/01/2023
COCHLEAR LIMITED Director/Board Member 20/07/2021
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Director/Board Member 06/07/2021
CSL LIMITED Director/Board Member 25/06/2021
░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Shah Hussain's experience

Training of Shah Hussain

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Lilly Pharma Holding GmbH

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services